Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma.
作者信息
Song Yu-Qin, Zhang Hui-Lai, Huang Hui-Qiang, Zhang Qing-Yuan, Jing Hong-Mei, Wang Chao, Wu Chun, Li Dong-Hang, Dai Yu, Humphrey Kathryn, Zhu Jun
机构信息
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing.
Tianjin Medical University Cancer Institute and Hospital, Tianjin.
出版信息
Haematologica. 2024 Apr 1;109(4):1269-1273. doi: 10.3324/haematol.2023.283802.
Abstract
摘要
Zotero 插件